The Discounted Cash Flow (DCF) valuation of Cytek Biosciences Inc (CTKB) is (3.12) USD. With the latest stock price at 4.53 USD, the upside of Cytek Biosciences Inc based on DCF is -168.8%.
Based on the latest price of 4.53 USD and our DCF valuation, Cytek Biosciences Inc (CTKB) is a sell. selling CTKB stocks now will result in a potential gain of 168.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.8% - 10.1% | 9.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (5.69) - (2.10) | (3.12) |
| Upside | -225.5% - -146.3% | -168.8% |